| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 42 | 2019 | 427 | 5.700 |
Why?
|
| Heart Failure | 19 | 2019 | 575 | 2.680 |
Why?
|
| Chest Pain | 17 | 2019 | 168 | 2.120 |
Why?
|
| Acute Coronary Syndrome | 12 | 2018 | 170 | 1.880 |
Why?
|
| Emergency Medical Services | 9 | 2019 | 150 | 1.470 |
Why?
|
| Patient Discharge | 9 | 2019 | 157 | 1.300 |
Why?
|
| Syncope | 2 | 2017 | 23 | 1.220 |
Why?
|
| Emergency Medicine | 6 | 2016 | 132 | 1.000 |
Why?
|
| Humans | 80 | 2019 | 29179 | 0.950 |
Why?
|
| Observation | 4 | 2017 | 23 | 0.890 |
Why?
|
| Myocardial Infarction | 9 | 2018 | 411 | 0.850 |
Why?
|
| Electrocardiography | 14 | 2018 | 564 | 0.800 |
Why?
|
| Venous Thromboembolism | 2 | 2018 | 25 | 0.790 |
Why?
|
| Emergency Treatment | 3 | 2019 | 43 | 0.760 |
Why?
|
| Educational Measurement | 4 | 2016 | 106 | 0.700 |
Why?
|
| Delivery of Health Care | 3 | 2015 | 131 | 0.680 |
Why?
|
| Hospital Units | 1 | 2017 | 2 | 0.650 |
Why?
|
| Guideline Adherence | 3 | 2019 | 108 | 0.630 |
Why?
|
| Length of Stay | 5 | 2015 | 286 | 0.620 |
Why?
|
| Male | 46 | 2019 | 18057 | 0.610 |
Why?
|
| Acute Disease | 14 | 2016 | 243 | 0.610 |
Why?
|
| Risk Assessment | 12 | 2016 | 1308 | 0.600 |
Why?
|
| Critical Pathways | 6 | 2018 | 47 | 0.600 |
Why?
|
| Female | 45 | 2019 | 18317 | 0.600 |
Why?
|
| Postural Balance | 2 | 2016 | 108 | 0.590 |
Why?
|
| Patient Admission | 2 | 2014 | 54 | 0.590 |
Why?
|
| Heart-Assist Devices | 3 | 2019 | 19 | 0.580 |
Why?
|
| Middle Aged | 37 | 2018 | 11174 | 0.570 |
Why?
|
| Hospitalization | 6 | 2018 | 397 | 0.560 |
Why?
|
| Clinical Clerkship | 2 | 2015 | 39 | 0.550 |
Why?
|
| Adult | 29 | 2018 | 8584 | 0.540 |
Why?
|
| Decision Support Techniques | 4 | 2017 | 100 | 0.540 |
Why?
|
| Triage | 3 | 2015 | 69 | 0.540 |
Why?
|
| Retrospective Studies | 17 | 2019 | 3120 | 0.530 |
Why?
|
| Referral and Consultation | 2 | 2016 | 110 | 0.530 |
Why?
|
| Wilderness Medicine | 1 | 2014 | 14 | 0.530 |
Why?
|
| Palliative Care | 1 | 2015 | 47 | 0.520 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 47 | 0.500 |
Why?
|
| Patient Care Team | 2 | 2014 | 117 | 0.490 |
Why?
|
| Teaching Rounds | 1 | 2013 | 7 | 0.480 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 313 | 0.480 |
Why?
|
| Vascular Diseases | 1 | 2013 | 62 | 0.470 |
Why?
|
| Clinical Competence | 6 | 2016 | 302 | 0.470 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2016 | 56 | 0.470 |
Why?
|
| Ischemia | 1 | 2013 | 93 | 0.470 |
Why?
|
| Logistic Models | 10 | 2018 | 724 | 0.460 |
Why?
|
| Mental Disorders | 1 | 2013 | 97 | 0.450 |
Why?
|
| Cause of Death | 1 | 2013 | 224 | 0.430 |
Why?
|
| Aged | 27 | 2018 | 9607 | 0.420 |
Why?
|
| Androstanols | 1 | 2011 | 3 | 0.420 |
Why?
|
| Succinylcholine | 1 | 2011 | 6 | 0.420 |
Why?
|
| Crack Cocaine | 1 | 2011 | 4 | 0.410 |
Why?
|
| Ambulances | 1 | 2011 | 10 | 0.410 |
Why?
|
| Abdominal Pain | 1 | 2011 | 39 | 0.410 |
Why?
|
| Alcoholic Intoxication | 1 | 2011 | 31 | 0.400 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 305 | 0.400 |
Why?
|
| Foot Injuries | 1 | 2010 | 11 | 0.400 |
Why?
|
| Social Environment | 1 | 2011 | 72 | 0.400 |
Why?
|
| Prospective Studies | 17 | 2018 | 1984 | 0.390 |
Why?
|
| Healthcare Disparities | 2 | 2011 | 139 | 0.390 |
Why?
|
| Ankle Injuries | 1 | 2010 | 19 | 0.390 |
Why?
|
| Intubation, Intratracheal | 1 | 2011 | 70 | 0.390 |
Why?
|
| Football | 1 | 2011 | 73 | 0.380 |
Why?
|
| Cardiology Service, Hospital | 3 | 2015 | 22 | 0.370 |
Why?
|
| Cocaine-Related Disorders | 1 | 2011 | 106 | 0.370 |
Why?
|
| Students | 1 | 2011 | 149 | 0.360 |
Why?
|
| Electronic Health Records | 1 | 2010 | 114 | 0.360 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2009 | 6 | 0.360 |
Why?
|
| Shock, Cardiogenic | 1 | 2009 | 7 | 0.360 |
Why?
|
| Accidental Falls | 1 | 2009 | 73 | 0.350 |
Why?
|
| United States | 14 | 2019 | 3636 | 0.350 |
Why?
|
| Neoplasms | 1 | 2015 | 608 | 0.340 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 144 | 0.330 |
Why?
|
| Physical Examination | 6 | 2016 | 80 | 0.320 |
Why?
|
| Natriuretic Agents | 1 | 2007 | 2 | 0.320 |
Why?
|
| Geriatric Assessment | 1 | 2009 | 325 | 0.320 |
Why?
|
| Time Factors | 11 | 2018 | 2010 | 0.310 |
Why?
|
| Registries | 7 | 2016 | 279 | 0.310 |
Why?
|
| Dyspnea | 4 | 2016 | 29 | 0.300 |
Why?
|
| Health Resources | 3 | 2015 | 31 | 0.280 |
Why?
|
| Substance Abuse Detection | 1 | 2005 | 4 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 889 | 0.270 |
Why?
|
| Saliva | 1 | 2005 | 33 | 0.270 |
Why?
|
| Ocular Hypertension | 1 | 2004 | 6 | 0.260 |
Why?
|
| Quality of Health Care | 2 | 2010 | 137 | 0.260 |
Why?
|
| Algorithms | 4 | 2019 | 468 | 0.260 |
Why?
|
| Intracranial Hypertension | 1 | 2004 | 20 | 0.250 |
Why?
|
| Postoperative Complications | 2 | 2019 | 678 | 0.250 |
Why?
|
| North Carolina | 9 | 2019 | 1408 | 0.250 |
Why?
|
| Internship and Residency | 3 | 2016 | 283 | 0.250 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 543 | 0.250 |
Why?
|
| Wounds and Injuries | 3 | 2015 | 248 | 0.250 |
Why?
|
| Disease Management | 2 | 2014 | 119 | 0.240 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2016 | 23 | 0.240 |
Why?
|
| Insurance Coverage | 1 | 2004 | 72 | 0.240 |
Why?
|
| Pesticides | 1 | 2016 | 188 | 0.240 |
Why?
|
| Labetalol | 2 | 2014 | 3 | 0.240 |
Why?
|
| Nicardipine | 2 | 2014 | 5 | 0.240 |
Why?
|
| Occupational Exposure | 1 | 2016 | 224 | 0.230 |
Why?
|
| Insurance, Health | 1 | 2004 | 90 | 0.230 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 231 | 0.230 |
Why?
|
| Predictive Value of Tests | 7 | 2018 | 788 | 0.230 |
Why?
|
| Transients and Migrants | 1 | 2016 | 280 | 0.230 |
Why?
|
| Emergencies | 2 | 2019 | 45 | 0.230 |
Why?
|
| Ethanol | 1 | 2005 | 183 | 0.230 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 231 | 0.220 |
Why?
|
| Aged, 80 and over | 10 | 2015 | 3733 | 0.220 |
Why?
|
| Coronary Angiography | 4 | 2018 | 141 | 0.210 |
Why?
|
| Troponin | 6 | 2018 | 76 | 0.210 |
Why?
|
| Consensus | 3 | 2019 | 69 | 0.210 |
Why?
|
| Pulmonary Embolism | 2 | 2012 | 44 | 0.210 |
Why?
|
| Societies, Medical | 2 | 2014 | 153 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 5 | 2010 | 378 | 0.200 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 705 | 0.200 |
Why?
|
| Young Adult | 4 | 2015 | 2403 | 0.200 |
Why?
|
| Regression Analysis | 3 | 2013 | 275 | 0.200 |
Why?
|
| Heart Auscultation | 2 | 2010 | 2 | 0.190 |
Why?
|
| Pilot Projects | 4 | 2014 | 458 | 0.190 |
Why?
|
| Exercise Test | 4 | 2016 | 190 | 0.190 |
Why?
|
| Antihypertensive Agents | 2 | 2014 | 378 | 0.180 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 34 | 0.180 |
Why?
|
| Hypoglycemia | 1 | 2019 | 41 | 0.180 |
Why?
|
| Hispanic Americans | 1 | 2016 | 947 | 0.180 |
Why?
|
| Seizures | 1 | 2019 | 57 | 0.180 |
Why?
|
| Catheterization, Central Venous | 2 | 2016 | 61 | 0.170 |
Why?
|
| Radiology Information Systems | 1 | 2018 | 13 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2016 | 912 | 0.170 |
Why?
|
| Vena Cava Filters | 1 | 2018 | 14 | 0.170 |
Why?
|
| Myocardial Revascularization | 2 | 2015 | 37 | 0.170 |
Why?
|
| Device Removal | 1 | 2018 | 31 | 0.170 |
Why?
|
| Vena Cava, Inferior | 1 | 2018 | 31 | 0.170 |
Why?
|
| Anaphylaxis | 1 | 2018 | 11 | 0.170 |
Why?
|
| Epinephrine | 1 | 2018 | 43 | 0.160 |
Why?
|
| Urban Health Services | 1 | 2017 | 10 | 0.160 |
Why?
|
| Rural Health Services | 1 | 2017 | 26 | 0.160 |
Why?
|
| Patient Education as Topic | 2 | 2017 | 230 | 0.160 |
Why?
|
| Bronchodilator Agents | 1 | 2018 | 82 | 0.160 |
Why?
|
| Troponin C | 1 | 2017 | 9 | 0.160 |
Why?
|
| Treatment Outcome | 7 | 2012 | 3114 | 0.150 |
Why?
|
| Cohort Studies | 7 | 2017 | 1709 | 0.150 |
Why?
|
| Hospitals, Rural | 1 | 2016 | 9 | 0.150 |
Why?
|
| Patient Selection | 1 | 2018 | 256 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2019 | 483 | 0.150 |
Why?
|
| Career Choice | 1 | 2016 | 38 | 0.150 |
Why?
|
| Jugular Veins | 1 | 2016 | 26 | 0.150 |
Why?
|
| Age Factors | 4 | 2018 | 1106 | 0.150 |
Why?
|
| Advance Directives | 1 | 2015 | 6 | 0.140 |
Why?
|
| Skilled Nursing Facilities | 1 | 2015 | 9 | 0.140 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 12 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 54 | 0.140 |
Why?
|
| Videotape Recording | 1 | 2015 | 12 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 1223 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2018 | 457 | 0.140 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 41 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2015 | 59 | 0.140 |
Why?
|
| Death | 1 | 2015 | 39 | 0.140 |
Why?
|
| Risk Factors | 7 | 2018 | 3550 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 90 | 0.140 |
Why?
|
| Risk | 1 | 2016 | 295 | 0.140 |
Why?
|
| Health Care Costs | 1 | 2016 | 104 | 0.140 |
Why?
|
| Hypertension | 2 | 2014 | 980 | 0.140 |
Why?
|
| Hospital Mortality | 3 | 2015 | 187 | 0.140 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 115 | 0.140 |
Why?
|
| Prognosis | 6 | 2018 | 1447 | 0.130 |
Why?
|
| Continental Population Groups | 2 | 2008 | 231 | 0.130 |
Why?
|
| American Heart Association | 2 | 2019 | 83 | 0.130 |
Why?
|
| Disasters | 1 | 2014 | 11 | 0.130 |
Why?
|
| Angioedema | 1 | 2014 | 3 | 0.130 |
Why?
|
| Databases, Factual | 4 | 2018 | 330 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 2130 | 0.130 |
Why?
|
| Decision Making | 1 | 2016 | 186 | 0.130 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 870 | 0.130 |
Why?
|
| Peptostreptococcus | 1 | 2013 | 3 | 0.130 |
Why?
|
| Empyema, Subdural | 1 | 2013 | 3 | 0.130 |
Why?
|
| Defibrillators, Implantable | 1 | 2014 | 17 | 0.130 |
Why?
|
| Ohio | 4 | 2018 | 49 | 0.130 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 54 | 0.130 |
Why?
|
| Lactates | 1 | 2013 | 2 | 0.130 |
Why?
|
| Frontal Sinusitis | 1 | 2013 | 5 | 0.130 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2013 | 9 | 0.130 |
Why?
|
| Health Surveys | 1 | 2014 | 188 | 0.120 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2013 | 17 | 0.120 |
Why?
|
| Education, Medical | 1 | 2014 | 71 | 0.120 |
Why?
|
| Mass Casualty Incidents | 1 | 2014 | 18 | 0.120 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 92 | 0.120 |
Why?
|
| Program Evaluation | 2 | 2011 | 163 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 43 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2013 | 19 | 0.120 |
Why?
|
| Headache | 1 | 2013 | 74 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 56 | 0.120 |
Why?
|
| Mortality | 1 | 2014 | 108 | 0.120 |
Why?
|
| Students, Medical | 1 | 2014 | 117 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 1310 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2014 | 141 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 455 | 0.120 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 12 | 0.110 |
Why?
|
| Professional Competence | 1 | 2012 | 17 | 0.110 |
Why?
|
| Curriculum | 1 | 2014 | 189 | 0.110 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2012 | 11 | 0.110 |
Why?
|
| Adolescent | 4 | 2019 | 3243 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2013 | 70 | 0.110 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 34 | 0.110 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 46 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 85 | 0.110 |
Why?
|
| Lipocalins | 1 | 2011 | 5 | 0.110 |
Why?
|
| Coronary Vessels | 1 | 2013 | 160 | 0.110 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 29 | 0.110 |
Why?
|
| Hospitals, Community | 1 | 2011 | 10 | 0.110 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2011 | 3 | 0.110 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 2011 | 5 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 302 | 0.110 |
Why?
|
| Air Ambulances | 1 | 2011 | 10 | 0.100 |
Why?
|
| Diagnosis, Differential | 4 | 2016 | 518 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 116 | 0.100 |
Why?
|
| Transportation of Patients | 1 | 2010 | 15 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2010 | 23 | 0.100 |
Why?
|
| Research Design | 1 | 2012 | 271 | 0.100 |
Why?
|
| Ankle | 1 | 2010 | 20 | 0.100 |
Why?
|
| Foot | 1 | 2010 | 37 | 0.100 |
Why?
|
| Documentation | 1 | 2010 | 30 | 0.100 |
Why?
|
| Survival | 1 | 2009 | 13 | 0.090 |
Why?
|
| Trauma Centers | 1 | 2010 | 85 | 0.090 |
Why?
|
| Universities | 1 | 2011 | 131 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2011 | 120 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2009 | 39 | 0.090 |
Why?
|
| Radiography | 1 | 2010 | 359 | 0.090 |
Why?
|
| Information Services | 1 | 2009 | 10 | 0.090 |
Why?
|
| African Continental Ancestry Group | 1 | 2011 | 378 | 0.090 |
Why?
|
| Thrombolytic Therapy | 2 | 2012 | 60 | 0.090 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 378 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2010 | 219 | 0.090 |
Why?
|
| Equipment Design | 1 | 2009 | 168 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2009 | 117 | 0.080 |
Why?
|
| Incidence | 3 | 2018 | 1098 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2009 | 155 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2008 | 55 | 0.080 |
Why?
|
| Pneumonia | 1 | 2008 | 61 | 0.080 |
Why?
|
| Child | 3 | 2019 | 2174 | 0.080 |
Why?
|
| Sex Factors | 1 | 2008 | 635 | 0.070 |
Why?
|
| European Continental Ancestry Group | 1 | 2011 | 1210 | 0.070 |
Why?
|
| Checklist | 2 | 2016 | 35 | 0.070 |
Why?
|
| Chromatography, Gas | 1 | 2005 | 3 | 0.070 |
Why?
|
| Radiography, Thoracic | 2 | 2016 | 42 | 0.070 |
Why?
|
| Reference Standards | 1 | 2005 | 29 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2005 | 106 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2005 | 63 | 0.070 |
Why?
|
| Tonometry, Ocular | 1 | 2004 | 6 | 0.060 |
Why?
|
| Singapore | 1 | 2004 | 10 | 0.060 |
Why?
|
| Ventriculostomy | 1 | 2004 | 11 | 0.060 |
Why?
|
| Intracranial Pressure | 1 | 2004 | 19 | 0.060 |
Why?
|
| Intraocular Pressure | 1 | 2004 | 27 | 0.060 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2004 | 31 | 0.060 |
Why?
|
| Intracranial Hemorrhages | 1 | 2004 | 31 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 155 | 0.060 |
Why?
|
| Survival Rate | 2 | 2016 | 824 | 0.060 |
Why?
|
| Health Personnel | 2 | 2015 | 100 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2004 | 189 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2004 | 62 | 0.060 |
Why?
|
| Age Distribution | 1 | 2004 | 200 | 0.060 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 87 | 0.060 |
Why?
|
| Medical History Taking | 2 | 2016 | 33 | 0.060 |
Why?
|
| Confidence Intervals | 2 | 2011 | 137 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 23 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2019 | 30 | 0.050 |
Why?
|
| International Cooperation | 1 | 2019 | 26 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2019 | 29 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2019 | 58 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2019 | 88 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 288 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 177 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 594 | 0.040 |
Why?
|
| Cost Savings | 1 | 2016 | 32 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2016 | 89 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2016 | 32 | 0.040 |
Why?
|
| Rural Population | 1 | 2018 | 229 | 0.040 |
Why?
|
| Mental Competency | 1 | 2015 | 6 | 0.040 |
Why?
|
| Ghana | 1 | 2015 | 22 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2018 | 581 | 0.040 |
Why?
|
| Cardiology | 1 | 2016 | 72 | 0.040 |
Why?
|
| Manikins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Developing Countries | 1 | 2015 | 39 | 0.030 |
Why?
|
| Echocardiography | 1 | 2016 | 143 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 22 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 91 | 0.030 |
Why?
|
| Animals | 1 | 2007 | 7435 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 948 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 429 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 19 | 0.030 |
Why?
|
| Lung | 1 | 2016 | 231 | 0.030 |
Why?
|
| Consciousness Disorders | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hematoma, Subdural | 1 | 2013 | 12 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1170 | 0.030 |
Why?
|
| Forecasting | 1 | 2014 | 132 | 0.030 |
Why?
|
| Fever | 1 | 2013 | 58 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 19 | 0.030 |
Why?
|
| Bacteremia | 1 | 2013 | 52 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 245 | 0.030 |
Why?
|
| Migraine Disorders | 1 | 2013 | 58 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 509 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2014 | 202 | 0.030 |
Why?
|
| Embolectomy | 1 | 2012 | 3 | 0.030 |
Why?
|
| Observer Variation | 1 | 2012 | 99 | 0.030 |
Why?
|
| Comorbidity | 1 | 2014 | 546 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2012 | 157 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2013 | 104 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 98 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2016 | 486 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 887 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 2011 | 4 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2011 | 10 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 722 | 0.030 |
Why?
|
| Regional Health Planning | 1 | 2010 | 6 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2010 | 28 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 82 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2011 | 97 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2010 | 116 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 150 | 0.020 |
Why?
|
| Phonocardiography | 1 | 2009 | 1 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 66 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 149 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 89 | 0.020 |
Why?
|
| Midwestern United States | 1 | 2008 | 8 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 2008 | 15 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 461 | 0.020 |
Why?
|
| Oximetry | 1 | 2008 | 27 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 462 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2009 | 235 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 535 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 140 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 887 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 201 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 874 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2005 | 207 | 0.020 |
Why?
|